d
  말레이시아
  바이오
  and
  QSG
 
KBCC : [08-08]    KBCC : [08-08]    CS on Mate : [08-08]    CS on Mate : [08-07]    ZETA presentation : [07-28]   

 
작성일 : 12-07-28 23:55
Indonesia needs central science fund
 글쓴이 : KBCC
조회 : 1,360  
THE Indonesian Academy of Sciences (AIPI) issued a bleak report last week on the state of the country's research and development (R&D) funding. But Indonesia's researchers are used to having their scientific ambitions held back by lack of funds.

Indonesia spends just 0.02 per cent (US$300 million) of its gross domestic product (GDP) on R&D, much lower than the one per cent that most developing countries aim for.

As the report points out, about 80 per cent of the country's R&D spending is government money, which gets tied up in bureaucratic red tape, stifling research.

AIPI proposes to unblock this by creating a central fund similar to the US National Science Foundation. This would distribute government R&D funds efficiently by streamlining the grant-giving process.

Innovative strategies such as these are just what Indonesia needs. The country is already seeing Malaysia, Thailand and Singapore soar above it -- in terms of both R&D investment and achievement.

Indonesia's science capacity has stagnated ever since the Asian financial crash in the late 1990s, and the political upheaval after the end of President Suharto's regime around the same time, which stifled progress in R&D.

Last year, the government launched an ambitious economic plan that would put science at the core of its development. But in one respect it is so ambitious as to be meaningless.

According to the plan, the country aims to spend one per cent of its GDP on R&D by 2014, already quite a challenge, but it also says it will spend three per cent by 2025. Currently, even the United States spends only about 2.6 per cent.

Such wildly ambitious plans do nothing to foster confidence among the public or researchers -- when the government fails yet again to deliver on its promise, scientists will become more cynical.

Indonesia is also desperate to drive applied research -- to find new medical technologies, for instance -- yet its basic research is seriously lacking. Somehow, the country wants to leapfrog the necessary steps from basic to applied research to reap the economic gains, but this will be impossible without a solid scientific base.

Last month, while researching a project for the United Kingdom Royal Society and the Organisation of Islamic Cooperation to map Indonesia's science and innovation capacity, I surveyed over a hundred scientists, university lecturers and policymakers to understand, among other issues, how funding affects biomedical research.

Researchers said that the short-term nature of funding was a major barrier to developing a globally competitive research strategy, because they often get grants for just a year at a time.

Pharmaceutical research suffers particularly from short-term funding, as drug R&D requires years of investment from discovery through to clinical trials. Without decent investment, Indonesian healthcare researchers are forced to import technology and churn out existing drugs in factories instead.

Health is also seriously affected by the lack of public-private partnerships in the country. As about 80 per cent of R&D spending comes from the government, most researchers work in state universities or in government R&D institutions -- private investment in R&D is negligible in Indonesia.

Not only is industry extremely risk-averse, spending virtually nothing on R&D, but compa-nies also do not cooperate with government research institutions because they view their mindsets as being too different.

Public institutions, meanwhile, see industry as only being out to make a profit.

Indonesia will need to alter radically this mutual scepticism, as public-private partnerships can be enormously beneficial to healthcare research in developing countries.

Finally, Indonesia needs to bring its intellectual property system up to speed. Patents drive biomedical research and innovation, yet many researchers are unaware of how patents can protect their work or bring in revenue, and often do not protect their findings.

Sangkot Marzuki, chairman of AIPI and director of the prestigious Eijkman Institute for Molecular Biology in Jakarta, has been keen to set up a central science fund for a long time.

Researchers need to be able to rely on sustained funding, and to know that their research will not be under threat every time the ruling political party changes, he says.

If Indonesia can pull this off -- no mean feat in a country where even the smallest administrative move must be signed in triplicate -- it could revolutionise R&D.

The country is keen to show the rest of the world that it is a global research player. Now it is time to make the first move. www.scidev.net



Read more: Indonesia needs central science fund - Columnist - New Straits Times http://www.nst.com.my/opinion/columnist/indonesia-needs-central-science-fund-1.113765#ixzz21vg37Rn8

 
   
 

 
 
 
 
 
 
 
 
 
     
 
     
 
     
 
Korean     |    English
 
KOREA KBCC 104-48 EUNHA BUILDING 202 DAEHYUN DONG SEODAEMUN GU SEOUL.KOREA TEL 82-2-715-0415 / FAX 82-2-711-0068
MALAYSIA KBCC BLOCK A-3A-2, JALAN EXCELLA. TAMAN AMPONG HITIR, 55100 KL MALAYSIA
UAE KBCC P.O BOX 73785 DUBAI,UAE TEL 971-50-870-1204 / FAX 971-3-755-9655